Previous Article | Next Article 
Journal of Clinical Microbiology, August 1999, p. 2548-2552, Vol. 37, No. 8
0095-1137/99/$04.00+0
Molecular Epidemiological Study of
Haemophilus influenzae Serotype b Strains Obtained from
Children with Meningitis in Japan
Toshihiro
Mitsuda,1,2,*
Haruo
Kuroki,3
Nobuyasu
Ishikawa,3
Tomoyuki
Imagawa,2
Schuichi
Ito,2
Takako
Miyamae,2
Masaaki
Mori,2
Suzuko
Uehara,3 and
Shumpei
Yokota2
Division of Clinical Laboratory
Medicine1 and Department of
Pediatrics,2 School of Medicine, Yokohama City
University, 3-9 Fukuura, Kanazawa-ku, Yokohama City, 236-0004, and
Department of Pediatrics, Chiba University School of
Medicine, 1-8-1 Inohana, Chuoh-ku, Chiba City, Chiba,
260-0856,3 Japan
Received 19 August 1998/Returned for modification 22 November
1998/Accepted 21 May 1999
 |
ABSTRACT |
We report an epidemiological study of 30 Haemophilus
influenzae serotype b (Hib) strains derived from the
cerebrospinal fluid of children with meningitis. The Hib strains were
biotyped, tested for
-lactamase production, and
genotyped by long PCR-ribotyping, random amplified polymorphic DNA
(RAPD) analysis, and genomic DNA restriction fragment length
polymorphism (RFLP) analysis by pulsed-field gel electrophoresis
(PFGE). The phenotypic study characterized 22 of the strains (73%) as
biotype I. A genotypic study using long PCR-ribotyping with
HaeIII restriction digestion showed no polymorphisms among
these 30 Hib strains, but RAPD analysis with two sets of primers
demonstrated two distinctive subtypes: one typical of the strains of
biotype group II and the second characteristic of the strains of
biotype groups I and IV. Each RAPD group was subtyped into several
genotypic groups by PFGE-RFLP with SmaI digestion. The
genotyping of clinically isolated Hib strains may help to elucidate
transmission routes in community infections, endemicity, and the
reasons for vaccine failure.
 |
INTRODUCTION |
Haemophilus influenzae
serotype b (Hib) has until recently been a leading cause of bacterial
meningitis and other invasive bacterial infections in childhood
worldwide; indeed, it is still the major cause of bacterial meningitis
in Japan (10). The aim of the present study was to
investigate the molecular epidemiology of clinically isolated Hib
strains derived from pediatric meningitis patients in Japan. This was
achieved by combining several molecular epidemiological methods
including long PCR-ribotyping (18, 19), random amplified
polymorphic DNA (RAPD) analysis (5), and restriction fragment length polymorphism (RFLP) analysis with the SmaI
restriction enzyme and the pulsed-field gel electrophoresis (PFGE)
apparatus (4, 6, 9).
 |
MATERIALS AND METHODS |
Bacterial strains.
All Hib strains (30 strains) were
isolated from the cerebrospinal fluid of children with meningitis,
ranging from 3 months to 5 years and 3 months old (mean ± standard deviation, 2 years ± 16 months), between March 1992 and
November 1995. Most of the strains were collected from the Kanto area
(Tokyo Bay area). Of these, 19 were collected from Chiba Prefecture
(four were collected from the Tokai area). All the bacterial strains
isolated from the cerebrospinal fluid samples were confirmed as
H. influenzae by conventional methods. They were biotyped by
the methods described by Kilian (12), and capsular serotype
b was confirmed with a commercial coagglutination kit (Phadebact
Haemophilus test; Pharmacia & Upjohn Japan, Tokyo, Japan).
The isolates were stored at
80°C, according to the procedures
described by Gibson and Khoury (8), until required for use.
The production of
-lactamase was assayed with Cefinase
discs (Becton Dickinson and Co., Cockeysville, Md.). Overnight cultures
of the Hib isolates grown in brain heart infusion broth (Oxoid,
Basingstoke, Hampshire, United Kingdom) supplemented with nicotinamide
adenine dinucleotide (2.0 µg/ml) and hemin (10 µg/ml) at 37°C in
5% CO2 were used to prepare DNA for the genotyping studies. Hib ATCC 10211 was used for PFGE-RFLP as a universal standard marker.
Long PCR-ribotyping and RAPD analysis.
Genomic DNA for the
PCR analyses was prepared with the SepaGene kit (Sanko Pharmaceutical
Co., Tokyo, Japan) and quantified by photospectrometry. Long
PCR-ribotyping was performed by the method described by Smith et al.
(19). Briefly, 270 ng of each sample DNA was amplified with
the 16S-H primer (5'-GGTATTGAGGAAGGTTGATGTGTTAATAGCACATC-3') and the 5S primer
(5'-CATTACAGCGTTTCACTTCTGAGTTCGGTATGGTC-3') with a
long-and-accurate (LA) PCR kit (TaKaRa LA PCR kit version 2; Takara
Shuzo, Tokyo, Japan). The LA PCR-amplified products were digested with
HaeIII (Takara Shuzo), electrophoresed in a 1.5% agarose
gel with 1× TBE buffer (50 mM Tris-HCl, 50 mM boric acid, and 1 mM
EDTA), and detected by ethidium bromide staining.
The PCR for RAPD analysis was performed with two different primers
(primer A, 5'-TGCCCGTCGT-3', and primer B,
5'-GTAGACCCGT-3') and the Ready-To-GO RAPD analysis kit
(Pharmacia Biotech AB, Uppsala, Sweden), which includes
AmpliTaq and the Stoffel fragment of Taq DNA
polymerase (5). Sample DNA (10 ng) was mixed with 25 pmol of
the primer in a standard PCR mixture. Amplification was performed with
a TwinBlock System Easy Cycler (Ericomp, San Diego, Calif.) thermal
cycler, programmed to carry out 1 cycle of 4 min at 95°C; 40 cycles
of 1 min at 94°C, 1 min at 36°C, and 2 min at 72°C; and 1 cycle
of 7 min at 72°C. The amplified products were resolved by
electrophoresis in a 2.5% agarose gel with 1× TBE buffer and detected
by ethidium bromide staining. For size determination, a 100-bp DNA
ladder (GIBCO BRL, Rockville, Md.) was used as a molecular size marker.
Chromosomal RFLP analysis by PFGE (PFGE-RFLP).
Genomic DNA
for the PFGE analysis was prepared by the procedure established by Hood
(9) with some modifications. Disposable 100-µl scale plug
molds (Bio-Rad) were used to prepare agarose plugs for each sample.
Overnight cultures of the Hib isolates were resuspended at 5 × 108 cells/ml in washing buffer A (100 mM NaCl, 20 mM
Tris-HCl, 20 mM EDTA, pH 7.6). Fifty microliters of each cell
suspension was used to prepare each plug. After treatment with
proteinase K (2 mg/ml) overnight at 52°C, the sample plugs were
incubated three times (for 30 min each time) with 2 ml of washing
buffer B (50 mM Tris-HCl, pH 7.5) containing 2 mM phenylmethylsulfonyl
fluoride at 50°C and then rinsed three times (for 30 min each time)
with 2 ml of washing buffer B. One-eighth of each plug was sliced off and digested with 10 U of SmaI (Takara Shuzo). The gels were
processed with the contour-clamped homogeneous electric field DR II
PFGE apparatus (Bio-Rad) under the following electrophoresis
conditions: 7 h at 170 V with an initial time of 5 s and a
final time of 20 s, followed by 14 h at 170 V with an initial
time of 5 s and a final time of 80 s. Electrophoresis was
performed in 0.5× TBE buffer at 11°C. A 48.5-kb lambda DNA ladder
(FMC BioProducts) was used as a molecular size marker. Hib ATCC 10211 DNA was used for PFGE-RFLP as a universal standard marker. After
electrophoresis, the gels were stained with ethidium bromide and
photographed under UV light at 302 nm.
Dendrograms.
The genomic DNA fingerprinting patterns
produced by PFGE-RFLP were analyzed with Molecular Analyst
Fingerprinting Plus software, version 1.12 (Bio-Rad) on a Microsoft
Windows 95 operating system to generate dendrograms (17).
The dendrogram was constructed with the unweighted pair group method
with averages clustering algorithm with the Jaccard coefficient
(SJ) with band positions.
 |
RESULTS |
Phenotypes.
Table 1 shows the
profiles of the clinically isolated Hib strains, including the
locations of the hospitals at which they were isolated, the ages of the
patients at the onset of Hib meningitis, RAPD data, and the results of
the
-lactamase production tests. Among the 30 Hib
strains, 22 (73.3%) were of biotype I, 6 (20.0%) were of biotype II,
and 2 (6.7%) were of biotype IV. There were no biotype III, V, VI, or
VII strains. Despite the fact that only four strains were isolated from
the Tokai area, two of the six biotype II Hib strains were isolated
from this area. Figure 1 shows the
locations of the hospitals at which the different strains were
isolated. Fifteen strains were
-lactamase producers.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 1.
Geographic location of a case study area. The geographic
distribution pattern of 30 pediatric meningitis patients in this study
is plotted on maps of Japan and Chiba Prefecture.
|
|
Long PCR-ribotyping and RAPD analysis of Hib strains.
The long
PCR-ribotyping method, which was originally developed to identify
nontypeable H. influenzae, showed no RFLPs among the Hib
isolates (all restriction patterns after HaeIII digestion were the same [data not shown]). RAPD analysis showed a number of
unique bands characteristic for a particular biotype with both primer
sets. When primer A was used (Fig. 2A),
the RAPD pattern exhibited a 600-bp band with biotype I or IV strains,
while when primer B was used (Fig. 2B), the RAPD pattern included a
380-bp band specific for biotype II strains. Strain 9, isolated from Toyohashi City, showed a unique band pattern compared with the other
strains with biotype I; however, this strain also fit the 600- and
380-bp band rule described above.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 2.
RAPD analysis of 30 Hib isolates from pediatric
meningitis patients. M, molecular size marker (100-bp DNA ladder). Lane
numbers correspond to the strain numbers in Table 1. (A) RAPD analysis
with primer A, 5'-TGCCCGTCGT-3'; (B) RAPD analysis with primer B,
5'-GTAGACCCGT-3'.
|
|
Chromosomal RFLP analysis by PFGE (PFGE-RFLP).
The chromosomal
RFLP patterns obtained after SmaI digestion of the 30 Hib
strains isolated are shown in Fig. 3. The
computer-generated graphic pattern and dendrogram also are shown in
Fig. 3. Five biotype II strains (no. 5, H93029; no. 6, H93130; no. 15, H94014; no. 22, H94207; and no. 24, H95048, which all exhibited a
380-bp band in their RAPD pattern as shown in Fig. 2B), no. 9 (H93175), and no. 14 (H93225) formed a cluster which includes three of the strains from the Tokai area. All of the strains isolated from Kisarazu
County in Chiba Prefecture, which were biotype I strains (no. 7, H93152; no. 10, H93184; no. 13, H93223; no. 20, H94084), were included
in the other large cluster.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Computer-generated graphic patterns and dendrogram by
PFGE-RFLP analysis of 30 Hib isolates from pediatric meningitis
patients. Strain numbers with isolate locations in Table 1 and H. influenzae ATCC 10211 are shown. A molecular size scale (upper
right) and a band-based Jaccard similarity coefficient (SJ
[%]) scale (upper left) are also shown.
|
|
 |
DISCUSSION |
There is a difference in the incidence of invasive Hib infectious
diseases between the United States and Japan. Uehara et al. reported
that the average annual incidence of H. influenzae meningitis per 100,000 children less than 5 years of age in Japan in
1994 was 4.0 cases (20), a much lower incidence than that of
24.0/100,000 reported by the National Bacterial Meningitis Reporting
System before the start of the Hib vaccination program in the United
States (1). The incidence of Hib meningitis in Japan has
been gradually increasing in recent years, and this may pose a future
risk of outbreaks of invasive Hib disease. Since Hib vaccines are not
currently available in Japan, the difference in the incidence of Hib
meningitis between Japan and the United States prior to the use of Hib
vaccines may be explained by the empiric therapy used for upper
respiratory infections in Japanese children, which is based on
prophylactic antibiotic usage. It has been recognized that the control
of invasive diseases caused by Hib requires routine immunization. We
are as yet unable to control invasive Hib disease well, despite early
diagnosis and appropriate treatment, because of the lack of a
vaccination program. Introduction of the Hib conjugate vaccine to Japan
is therefore necessary. Of the Hib meningitis strains isolated during
this study, 73% were of biotype I. The Hib strains isolated from
healthy carriers were mainly of biotypes I, II, and IV. Biotype I
strains were the most frequently isolated, reflecting the biotype
distribution of the strains of Hib responsible for invasive diseases.
In Japan, more than half of the invasive strains of Hib are of biotype
I (16).
In this study, PFGE-RFLP analysis of Hib DNA after digestion with
SmaI demonstrated several genotype groups. This technique may therefore be useful in clarifying the strain(s) endemic in certain
regions. Epidemiological studies of Hib infections commonly use
phenotyping (serotyping, biotyping, and analysis of the major outer
membrane protein patterns) (3, 15) or ribotyping methods (14, 18, 19). Recently, epidemiological studies of Hib
strains isolated from vaccinated patients have been performed. Falla et al. reported that there was no difference in the distribution of cap b
genotypes [i.e., b(S), b(G), b(V), or b(O)] between Hib strains
causing disease in Hib vaccine recipients and those isolated from
nonrecipients (7), suggesting that the cap b gene subtypes do not explain the virulence of Hib strains. van Alphen et al. reported
a reduction in the incidence of disease caused by all clonal groups of
Hib associated with widespread infant vaccination in Finland
(21).
PFGE analysis is currently considered the most reliable and practical
tool for molecular epidemiologic analyses of bacterial infections
(2, 4, 6, 9, 11). As demonstrated here, additional RAPD
analysis can increase the accuracy of these analyses. PCR-based RAPD
analysis is increasingly being used for molecular epidemiologic
applications, such as the subtyping of Escherichia coli
isolates (5). Although RAPD can provide RFLP data very rapidly, the resolution and reproducibility of these data are somewhat
limited. Nevertheless, RAPD can yield valuable preliminary molecular
epidemiologic information during bacterial outbreaks while more
time-consuming PFGE analyses are performed. The major limitations of
PFGE analysis include requirements for technical skill and expensive
apparatus and the time taken to complete the analysis (4 to 7 days).
Kits for performing amplified fragment length polymorphism
(Keygene, N.V., Wageningen, The Netherlands) recently have been
developed and are now commercially available (22), and this
will improve the resolutions for molecular epidemiological analysis.
Another area of interest in the study of Hib invasive diseases is the
existence and contribution of b
H. influenzae
strains. Loss of capsular b expression has frequently been demonstrated
under both in vivo and in vitro conditions. Identification of
b
strain carriers among healthy children is therefore
important, since b
H. influenzae strains or
non-b-serotyped H. influenzae strains may be capable of
gaining virulence by natural DNA transfer between Haemophilus strains (13). More attention
must be paid to genetic studies of Hib diseases caused by
b
and non-b-serotyped H. influenzae strains
after vaccination to explain and reduce vaccine failures. We are
currently planning to expand our Hib PFGE-RFLP study both nationwide
and within smaller communities to allow better understanding of the
routes of transmission of Hib and b
and non-b-serotype
H. influenzae infections.
 |
ACKNOWLEDGMENTS |
We thank all the doctors who offered Hib strains for this study.
We also thank Yukiko Abe, Bio-Rad Japan, for her technical support.
This research was partially supported by the Ministry of Education,
Science, Sports and Culture of Japan (Grant-in-Aid for Scientific
Research [C], no. 10670745, 1998).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pediatrics, School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama City, 236-0004, Japan. Phone: 81-45-787-2671. Fax: 81-45-784-3615. E-mail:
tmitsuda{at}med.yokohama-cu.ac.jp.
 |
REFERENCES |
| 1.
|
Adams, W. G.,
K. A. Deaver,
S. L. Cochi,
B. D. Plikaytis,
E. R. Zell,
C. V. Broome, and J. D. Wenger.
1993.
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.
JAMA
269:221-226[Abstract].
|
| 2.
|
Aparicio, P.,
F. Roman, and J. Campos.
1996.
Epidemiological characterization of Haemophilus influenzae using molecular markers.
Enferm. Infecc. Microbiol. Clin.
14:227-232[Medline].
|
| 3.
|
Bijlmer, H. A.,
A. L. van Alphen,
L. Geelen-van den Broek,
B. M. Greenwood,
H. A. Valkenburg, and J. Dankert.
1992.
Molecular epidemiology of Haemophilus influenzae type b in The Gambia.
J. Clin. Microbiol.
30:386-390[Abstract/Free Full Text].
|
| 4.
|
Butler, P. D., and E. R. Moxon.
1990.
A physical map of the genome of Haemophilus influenzae type b.
J. Gen. Microbiol.
136:2333-2342[Medline].
|
| 5.
|
Cave, H.,
E. Bingen,
J. Elion, and E. Denamur.
1994.
Differentiation of Escherichia coli strains using randomly amplified polymorphic DNA analysis.
Res. Microbiol.
145:141-150[Medline].
|
| 6.
|
Chachaty, E.,
P. Saulnier,
A. Martin,
N. Mario, and A. Andremont.
1994.
Comparison of ribotyping, pulsed-field gel electrophoresis and random amplified polymorphic DNA for typing Clostridium difficile strains.
FEMS Microbiol. Lett.
122:61-68[Medline].
|
| 7.
|
Falla, T. J.,
D. W. Crook,
E. C. Anderson,
J. I. Ward,
M. Santosham,
J. Eskola, and E. R. Moxon.
1995.
Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.
J. Infect. Dis.
171:1075-1076[Medline].
|
| 8.
|
Gibson, L. F., and J. T. Khoury.
1986.
Storage and survival of bacteria by ultra-freeze.
Lett. Appl. Microbiol.
3:127-129.
|
| 9.
|
Hood, D. W.
1995.
PFGE in the study of a bacterial pathogen (Haemophilus influenzae), p. 159-176.
In
A. P. Monaco (ed.), Pulsed field gel electrophoresis: a practical approach. IRL Press, New York, N.Y.
|
| 10.
|
Ishikawa, T.,
Y. Asano,
T. Morishima,
M. Nagashima,
G. Sobue,
K. Watanabe, and H. Yamaguchi.
1996.
Epidemiology of bacterial meningitis in children: Aichi Prefecture, Japan, 1984-1993.
Pediatr. Neurol.
14:244-250[Medline].
|
| 11.
|
Izumiya, H.,
J. Terajima,
A. Wada,
Y. Inagaki,
K. Itoh,
K. Tamura, and H. Watanabe.
1997.
Molecular typing of enterohemorrhagic Escherichia coli O157:H7 isolates in Japan by pulsed-field gel electrophoresis.
J. Clin. Microbiol.
35:1675-1680[Abstract].
|
| 12.
|
Kilian, M.
1976.
A taxonomic study of the genus Haemophilus, with the proposal of a new species.
J. Gen. Microbiol.
93:9-62[Medline].
|
| 13.
|
Kroll, J. S., and R. Booy.
1996.
Haemophilus influenzae: capsule vaccine and capsulation genetics.
Mol. Med. Today
2:160-165[Medline].
|
| 14.
|
Leaves, N. I., and J. Z. Jordens.
1994.
Development of a ribotyping scheme for Haemophilus influenzae type b.
Eur. J. Clin. Microbiol. Infect. Dis.
13:1038-1045[Medline].
|
| 15.
|
Musser, J. M.,
J. S. Kroll,
D. M. Granoff,
E. R. Moxon,
B. R. Brodeur,
J. Campos,
H. Dabernat,
W. Frederiksen,
J. Hamel,
G. Hammond, et al.
1990.
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae.
Rev. Infect. Dis.
12:75-111[Medline].
|
| 16.
|
Nakamura, A.,
N. Ishikawa,
H. Kuroki,
T. Yamazaki,
H. Suzuki,
C. Matsumura,
M. Namba,
K. Himi, and S. Uehara.
1989.
Clinical bacteriology of Haemophilus influenzae strains isolated from pediatric patients with systemic infections in Japan.
J. Jpn. Pediatr. Soc.
93:890-897.
|
| 17.
|
Schmid, J.,
E. Voss, and D. R. Soll.
1990.
Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3.
J. Clin. Microbiol.
28:1236-1243[Abstract/Free Full Text].
|
| 18.
|
Smith, V. H.,
A. J. Leach,
J. T. Shelby,
K. Kemp,
D. J. Kemp, and J. D. Mathews.
1996.
Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in aboriginal infants with otitis media.
Epidemiol. Infect.
116:177-183[Medline].
|
| 19.
|
Smith, V. H.,
K. S. Sriprakash,
J. D. Mathews, and D. J. Kemp.
1995.
Long PCR-ribotyping of nontypeable Haemophilus influenzae.
J. Clin. Microbiol.
33:1192-1195[Abstract].
|
| 20.
|
Uehara, S.,
H. Kamiya,
T. Togashi,
T. Kato,
K. Shiraki, and T. Morishima.
1998.
Epidemiology of Haemophilus influenzae meningitis among infants and children in Japan comparison with incidences of bacterial meningitis.
J. Jpn. Pediatr. Soc.
102:656-665.
|
| 21.
|
van Alphen, L.,
A. K. Takala,
B. L. Geelen,
J. Dankert, and J. Eskola.
1992.
Changes in the distribution of Haemophilus influenzae type b clones associated with widespread infant vaccination in Finland.
J. Infect. Dis.
166:1340-1345[Medline].
|
| 22.
|
Vos, P.,
R. Hogers,
M. Bleeker,
M. Reijans,
T. van de Lee,
M. Hornes,
A. Frijters,
J. Pot,
J. Peleman, and M. Kuiper.
1995.
AFLP: a new technique for DNA fingerprinting.
Nucleic Acids Res.
23:4407-4414[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, August 1999, p. 2548-2552, Vol. 37, No. 8
0095-1137/99/$04.00+0
This article has been cited by other articles:
-
Skoczynska, A., Kadlubowski, M., Empel, J., Hryniewicz, W.
(2005). Characteristics of Haemophilus influenzae Type b Responsible for Meningitis in Poland from 1997 to 2004. J. Clin. Microbiol.
43: 5665-5669
[Abstract]
[Full Text]
-
SHARMA, A., KAUR, R., GANGULY, N.K., SINGH, P.D., CHAKRABORTI, A.
(2002). Subtype distribution of Haemophilus influenzae isolates from North India. J Med Microbiol
51: 399-404
[Abstract]
[Full Text]
-
WANG, C.-C., SIU, L.K., CHEN, M.-K., YU, Y.-L., LIN, F.M., HO, M., CHU, M.-L.
(2001). Use of automated riboprinter and pulsed-field gel electrophoresis for epidemiological studies of invasive Haemophilus influenzae in Taiwan. J Med Microbiol
50: 277-283
[Abstract]
[Full Text]
-
Okatani, A. T., Hayashidani, H., Takahashi, T., Taniguchi, T., Ogawa, M., Kaneko, K.-i.
(2000). Randomly Amplified Polymorphic DNA Analysis of Erysipelothrix spp.. J. Clin. Microbiol.
38: 4332-4336
[Abstract]
[Full Text]